Parabilis Medicines, Inc. (PBLS)

NASDAQ: PBLS · Real-Time Price · USD

40.42

-0.33 (-0.81%)

At close: Sep 4, 2026, 4:00 PM EDT

39.31

-1.11 (-2.75%)

After-hours: Sep 4, 2026, 7:45 PM EDT

Parabilis Medicines Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-171.54	-147.85	-121.96
Net Income	-231.67	-186.93	-161.48
Earnings Per Share	-23.45	-60.04	-54.25
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,121	27.71	87.98
Total Debt	47.51	58.7	66.2
Net Cash (Debt)	1,073	-30.99	21.78
Net Cash Growth	-	-	-
Net Cash Per Share	108.61	-9.95	7.32

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-111.29	-123.71	-103.61
Capital Expenditures	-1.2	-0.31	-0.88
Free Cash Flow	-112.49	-124.02	-104.49
Free Cash Flow Growth	-	-	-